Immigrant women and cervical cancer screening in a private gynecology center in Quito - Ecuador
Keywords:
cervical cancer, screening, immigrants, cytology, molecular probesAbstract
Objective: immigrant women face health problems and challenges to access health care, no matter what destination country they choose. Regarding cervical cancer screening and prevention, migrant women access to a health care programme is an important issue. Some studies have shown that while migration is recent (under 10 years), is less likely to get cervical cancer examination services comparing with non-immigrant women. The hypothesis stated that immigrant women would have lower rates of screening and a higher prevalence of HPV related lesions, compared to those women from Ecuador.
Methods: a 12 months period study was performed including 113 women age 17 to 55, split into two groups: 56 migrant/refugee and 57 Ecuadorian residents, using cervical cytology and a DNA for HPV test based on hybrid capture II. Agreements between community organizations and private providers were reached to help the groups.
Results: both groups, Ecuadorian women (14.15%, n=16) and immigrant women (5.3%, n=6) that never had a Papanicolaou test, have HPV-DNA test positive for high and low risk types. Ecuadorian residents have access to cervical cytology regardless their age, while immigrant/refugee women under 30 years have not access to the test, the difference is statistically significant.
Conclusions: there is a significant difference in screening levels for cervical cancer between immigrant/refugee women according to place of origin and duration of stay in Ecuador.
Downloads
References
World Health Organization. Cervical Cancer Screening in Developing Countries: report of a WHO consultation. 2002.
Parikh S BP. Meta-Analysis of Social Inequality and the Risk of cervical Cancer. 2003;105:687-691. Int J Cancer 2003;105:687-691.
World Health Organization. Initiative for vaccine research: human papillomavirus. [Online]. Disponible en: http://www.who.int/vaccine_research/diseases/viral_cancers/en/index3.html#diseaseburden.
WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. [Online]. 2013 [cited 2017. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK195239/.
Organización Mundial de la Salud. Control integral del cáncer cervicouterino: guía de prácticas esenciales, 2da. ed. [Online]. 2015 [cited 2017. Available from: http://www.rho.org/files/WHO_CC_control_sp_2014.pdf.
Swaminathan R LESR. Cancer survival in Africa, Asia, the Caribbean and Central America: database and attributes. IARC Sci. Publ 2011;162:23-31.
de Sanjose S QWALGDKJLBea. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 2010;11(11):1048-1056.
Lipson JG HTKSOPEF. Health issues among Afghan women in California. Health Care Women Int 1995;16(4):279-286.
Ferlay J HRSBFFDMCMPD. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer 2010;127(12):2893-2917.
Dunne EF UESMMGSDPSML. Prevalence of HPV infection among females in the United States. JAMA 2007;297(8):813-819.
Sancho-Garnier H TCHPLFLRLDKea. HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France. Int J Cancer 2013;133(11):2681-2687.
Pino MA AM. Análisis de la situación del cáncer de cérvix uterino en el Ecuador, 2006. Revista Española de Patología 2008;41(1).
Tanca Campozano J ASC. Incidencia del cáncer en Guayaquil 2003-2006. Rev Oncol enero-junio, 20(1).
Páez C. KR,YN,MGAI,CF,SS,aYA. Prevalence of HPV DNA in Cervical Lesions in Patients from Ecuador and Japan. Tohoku J Exp Med 1996;180(3):261-272.
Ministerio de Salud Púbica del Ecuador. 21. Protocolos con evidencia para la detección oportuna del cáncer de cuello uterino. 2015. [Online]. [cited 2017 Feb. Disponible en: https://www.google.com.ec/lsa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=8&ved=0ahUKEwitpej55IvTAhWGKyYKHdP4A0kQFggYMAA&url=https%3A%2F%2Faplicaciones.msp.gob.ec%2Fsalud%2Farchivosdigitales%2Fsigobito%2Ftareas_seguimiento%2F1614%2Fprotocolos_cancer.
Tsui J SMTTDAaRL. Journal of Women's Health. Cervical Cancer Screening among Foreign-Born Women by Birthplace and Duration in the United States. 2007;16(10):1447-1457.
United Nations High Commissioner for Refugees (UNHCR). UNHCR Statistical Yearbook 2014, Demographic and Location Data. [Online].; 2014 [cited 2017. Available from: http://www.unhcr.org/56655f4c16.html.
Swan J BNCRRBLN. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer 2003;97(6):1528-1540.
Lazcano-Ponce EC CRABNPAdRPHAM. Barriers to early detection of cervical-uterine cancer in Mexico. J. Womens Health 1999;8(3):399-408.
Ndukwe EG WKSV. Knowledge and perspectives of breast and cervical cancer screening among female African immigrants in the Washington D.C. metropolitan area. J Cancer Educ 2013;28(4):748-754.
Carreras R XJCM. Virus del Papiloma Humano y Cáncer de Cuello Uterino, 1ra. ed. Editorial Médica Panamericana. Madrid, Buenos Aires. 2007.
Gao W1 PJDRLT. Demographic predictors of cervical cancer screening in Chinese women in New Zealand. N Z Med J 2008;121(1277):8-17.
Kreuger FA1 vOHNH. Cervical cancer screening: spatial associations of outcome and risk factors in Rotterdam. Public Health 1999;113(3): 111-115.
Coughlin SS1 WK. Breast and cervical cancer screening among migrant and seasonal farmworkers: a review. Cancer Detect Prev 2002;26(3):203-209.
Levinson KL ACSJCEZJBSea. The Peru Cervical Cancer Prevention Study (PERCAPS): the technology to make screening accessible. Gynecol Oncol 2013;129(2):318-323.
Newell A SAHRBF. Sexually transmitted diseases, cervical cytology and contraception in immigrants and refugees from the former Yugoslavia. Venereology 1998;11(1):25-27.
Taylor RJ1 MHMSWG. Cervical screening in migrants to Australia. Aust N Z J Public Health 2001;25(1):55-61.
Nguyen-Truong CK LLFLMGDVNLWPea. A community-based participatory research approach to understanding pap testing adherence among Vietnamese American immigrants. 2012;41:E26. J Obstet Gynecol Neonatal Nurs 2012;41(6):E26-40.
Sankaranarayanan R BARR. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull. World Health Organ 2001;79(10): 954-962.
Tornesello ML1 CRDRNBLMAVGPSSVPRBF. High prevalence of human papillomavirus infection in Eastern European and West African women immigrants in South Italy. APMIS 2011;119(10):701-709.
Bansil P WSLJWJPPJJ. Acceptability of self-collection sampling for HPV-DNA testing in low-resource settings: a mixed methods approach. BMC Public Health 2014;14:596.
Tamalet C1 RHCXHMLLHPLFSGHPL. Testing for human papillomavirus and measurement of viral load of HPV 16 and 18 in self-collected vaginal swabs of women who do not undergo cervical cytological screening in Southern France. J Med Virol 2010;82(8):1431-1437.
Lewis M. Análisis de la situación de cáncer cervicouterino en América Latina y el Caribe. [Online]. 2004 [cited 2017 Jan. Disponible en: http://www1.paho.org/spanish/ad/dpc/nc/pcc-cc-sit-lac.pdf.
International Agency for Research on Cancer, World Health Organization. Cancer survival in Africa, Asia, the Caribbean and Central America: database and attributes. IARC Sci Publ 2011;162:23–31 [Online]. 2011 [cited 2017 Jan. Disponible en: http://lapr-lda.com/wp-content/uploads/2015/07/para_testes_0.pdf.
Dzuba IG DEABLYLPESKea. The acceptability of self-collected samples for HPV testing vs. the pap test as alternatives in cervical cancer screening. J Womens Health Gend Based Med 2002;11(3):265-275.
Coughlin SS WK. Breast and cervical cancer screening among migrant and seasonal farmworkers: a review. Cancer Detect Prev 2002;26(3):203-209.
Gao W1 PJDRLT. Demographic predictors of cervical cancer screening in Chinese women in New Zealand. N Z Med J 2008;121(1277):8-17.
Downloads
Published
Issue
Section
License
Copyright (c) 2017 Guillermo Páez Coello, Marco Antonio Pino Bedón, Francisco Pérez Pazmiño
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
